Demographic Turning Points for the United States: Population Projections for 2020 to 2060,” [Internet]. Current Population Reports, P25–1144, U.S. Census Bureau, Washington, DC; 2020.

Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart Disease and Stroke Statistics—2022 Update: a report from the American Heart Association. Circulation [Internet]. 2022 Feb 22 [cited 2022 Mar 10];145(8). Available from: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001052. Accessed 6 Mar 2022.

Bergström G, Persson M, Adiels M, Björnson E, Bonander C, Ahlström H, et al. Prevalence of subclinical coronary artery atherosclerosis in the general population. Circulation. 2021;144(12):916–29.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Jaul E, Barron J. Age-related diseases and clinical and public health implications for the 85 years old and over population. Front Public Health. 2017;11(5):335.

Article  Google Scholar 

Kaski JC, Tamargo J, Savarese G. Cardiovascular pharmacotherapy in older people: challenges posed by cardiovascular drug prescription in the elderly. Eur Heart J - Cardiovasc Pharmacother. 2020;6(5):277–9.

PubMed  Article  Google Scholar 

Kaye AB, Bhakta A, Moseley AD, Rao AK, Arif S, Lichtenstein SJ, et al. Review of cardiovascular drugs in pregnancy. J Women’s Health. 2019;28(5):686–97.

Article  Google Scholar 

Khezrian M, McNeil CJ, Murray AD, Myint PK. An overview of prevalence, determinants and health outcomes of polypharmacy. Ther Adv Drug Saf. 2020;11:204209862093374.

Article  Google Scholar 

Rambhade S, Chakarborty A, Shrivastava A, Patil UK, Rambhade A. A survey on polypharmacy and use of inappropriate medications. Toxicol Int. 2012;19(1):68–73.

PubMed  PubMed Central  Article  Google Scholar 

Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230.

PubMed  PubMed Central  Article  Google Scholar 

Scottish Government Polypharmacy Model of Care Group. Polypharmacy guidance, realistic prescribing, 3rd ed. Scotland: Scottish Government, 2018. Available at https://www.therapeutics.scot.nhs.uk/wp-content/uploads/2018/04/Polypharmacy-Guidance-2018.pdf. Accessed 10 Mar 2022.

National Center for Health Statistics. Health, United States, 2019: Table 39. Hyattsville, MD. 2021. Available from: https://www.cdc.gov/nchs/hus/contents2019.htm. Accessed 10 Mar 2022.

Haas DM, Marsh DJ, Dang DT, Parker CB, Wing DA, Simhan HN, et al. Prescription and other medication use in pregnancy. Obstet Gynecol. 2018;131(5):789–98.

PubMed  PubMed Central  Article  Google Scholar 

Rhee TG, Kumar M, Ross JS, Coll PP. Age-related trajectories of cardiovascular risk and use of aspirin and statin among US adults aged 50 or older, 2011–2018. J Am Geriatr Soc. 2021;69(5):1272–82.

PubMed  Article  Google Scholar 

Fortin M, Stewart M, Poitras ME, Almirall J, Maddocks H. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med. 2012;10(2):142–51.

PubMed  PubMed Central  Article  Google Scholar 

Boyd CM, Leff B, Wolff JL, Yu Q, Zhou J, Rand C, et al. Informing clinical practice guideline development and implementation: prevalence of coexisting conditions among adults with coronary heart disease. J Am Geriatr Soc. 2011;59(5):797–805.

PubMed  Article  Google Scholar 

Lorgunpai SJ, Grammas M, Lee DSH, McAvay G, Charpentier P, Tinetti ME. Potential therapeutic competition in community-living older adults in the US: use of medications that may adversely affect a coexisting condition. PLoS ONE. 2014;9(2):e89447 (Quinn TJ, editor).

PubMed  PubMed Central  Article  CAS  Google Scholar 

Forman DE, Maurer MS, Boyd C, Brindis R, Salive ME, Horne FM, et al. Multimorbidity in older adults with cardiovascular disease. J Am Coll Cardiol. 2018;71(19):2149–61.

PubMed  PubMed Central  Article  Google Scholar 

Krishnaswami A, Steinman MA, Goyal P, Zullo AR, Anderson TS, Birtcher KK, et al. Deprescribing in older adults with cardiovascular disease. J Am Coll Cardiol. 2019;73(20):2584–95.

PubMed  PubMed Central  Article  Google Scholar 

Rochon PA, Gurwitz JH. The prescribing cascade revisited. Lancet. 2017;389(10081):1778–80.

PubMed  Article  Google Scholar 

• Savage RD, Visentin JD, Bronskill SE, Wang X, Gruneir A, Giannakeas V, et al. Evaluation of a common prescribing cascade of calcium channel blockers and diuretics in older adults with hypertension. JAMA Intern Med. 2020;180(5):643. This study brings to light the increased incidence of prescribing cascade in older adults with hypertension receiving calcium channel blockers. Increasing awareness of common prescribing cascade patterns is crucial to reduce unnecessary medication related harm.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Wastesson JW, Morin L, Tan ECK, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018;17(12):1185–96.

PubMed  Article  Google Scholar 

Martinez-Gomez D, Guallar-Castillon P, Higueras-Fresnillo S, Banegas JR, Sadarangani KP, Rodriguez-Artalejo F. A healthy lifestyle attenuates the effect of polypharmacy on total and cardiovascular mortality: a national prospective cohort study. Sci Rep. 2018;8(1):12615.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Mauvais-Jarvis F, BaireyMerz N, Barnes PJ, Brinton RD, Carrero JJ, DeMeo DL, et al. Sex and gender: modifiers of health, disease, and medicine. Lancet. 2020;396(10250):565–82.

PubMed  PubMed Central  Article  Google Scholar 

Franconi F, Campesi I. Sex and gender influences on pharmacological response: an overview. Expert Rev Clin Pharmacol. 2014;7(4):469–85.

PubMed  Article  CAS  Google Scholar 

Santema BT, Ouwerkerk W, Tromp J, Sama IE, Ravera A, Regitz-Zagrosek V, et al. Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study. The Lancet. 2019;394(10205):1254–63.

Article  CAS  Google Scholar 

Rydberg DM, Holm L, Mejyr S, Loikas D, Schenck-Gustafsson K, von Euler M, et al. Sex differences in spontaneous reports on adverse bleeding events of antithrombotic treatment. Eur J Clin Pharmacol. 2014;70(1):117–26.

PubMed  Article  CAS  Google Scholar 

Trenaman SC, Rideout M, Andrew MK. Sex and gender differences in polypharmacy in persons with dementia: a scoping review. SAGE Open Med. 2019;7:2050312119845715.

PubMed  PubMed Central  Article  Google Scholar 

Venturini CD, Engroff P, Ely LS, de Araújo Zago LF, Schroeter G, Gomes I, et al. Gender differences, polypharmacy, and potential pharmacological interactions in the elderly. Clinics (Sao Paulo). 2011;66(11):1867–72.

Google Scholar 

Soldin OP, Mattison DR. Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2009;48(3):143–57.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Solola Nussbaum S, Henry S, Yong CM, Daugherty SL, Mehran R, Poppas A. Sex-specific considerations in the presentation, diagnosis, and management of ischemic heart disease. J Am Coll Cardiol. 2022;79(14):1398–406.

PubMed  Article  Google Scholar 

Gordon EH, Peel NM, Samanta M, Theou O, Howlett SE, Hubbard RE. Sex differences in frailty: a systematic review and meta-analysis. Exp Gerontol. 2017;89:30–40.

PubMed  Article  CAS  Google Scholar 

Nwadiugwu MC. Frailty and the risk of polypharmacy in the older person: enabling and preventative approaches. J Aging Res. 2020;2020:6759521.

PubMed  PubMed Central  Article  Google Scholar 

Veronese N, Stubbs B, Noale M, Solmi M, Pilotto A, Vaona A, et al. Polypharmacy is associated with higher frailty risk in older people: an 8-year longitudinal cohort study. J Am Med Dir Assoc. 2017;18(7):624–8.

PubMed  PubMed Central  Article  Google Scholar 

Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of “deprescribing” with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254–68.

PubMed  PubMed Central  Article  Google Scholar 

•• Schwartz JB, Schmader KE, Hanlon JT, Abernethy DR, Gray S, Dunbar-Jacob J, et al. Pharmacotherapy in older adults with cardiovascular disease: report from an American College of Cardiology, American Geriatrics Society, and National Institute on Aging Workshop. J Am Geriatr Soc. 2019;67(2):371–80. This paper discusses the current research needs to optimize pharmacotherapy in older adults with cardiovascular diseases. The current gaps and needs were identified at a multidisciplinary workshop supported by the National Institute on Aging, the American College of Cardiology, and the American Geriatrics Society.

PubMed  Google Scholar 

Rossello X, Pocock SJ, Julian DG. Long-term use of cardiovascular drugs. J Am Coll Cardiol. 2015;66(11):1273–85.

PubMed  Article  CAS  Google Scholar 

Coll PP, Roche V, Olsen JS, Voit JH, Bowen E, Kumar M. The prevention of cardiovascular disease in older adults. J Am Geriatr Soc. 2020;68(5):1098–106.

PubMed  Article  Google Scholar 

Holt A, Blanche P, Zareini B, Rajan D, El-Sheikh M, Schjerning AM, et al. Effect of long-term beta-blocker treatment following myocardial infarction among stable, optimally treated patients without heart failure in the reperfusion era: a Danish, nationwide cohort study. Eur Heart J. 2021;42(9):907–14.

PubMed  Article  Google Scholar 

Kutner JS, Blatchford PJ, Taylor DH, Ritchie CS, Bull JH, Fairclough DL, et al. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. JAMA Intern Med. 2015;175(5):691–700.

PubMed  PubMed Central  Article  Google Scholar 

Moonen JEF, Foster-Dingley JC, de Ruijter W, van der Grond J, Bertens AS, van Buchem MA, et al. Effect of discontinuation of antihypertensive treatment in elderly people on cognitive functioning–the DANTE Study Leiden: a randomized clinical trial. JAMA Intern Med. 2015;175(10):1622–30.

PubMed  Article  Google Scholar 

Luymes CH, Poortvliet RKE, van Geloven N, de Waal MWM, Drewes YM, Blom JW, et al. Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice - the ECSTATIC study: a cluster randomised non-inferiority trial. BMC Med. 2018;16(1):5.

PubMed  PubMed Central  Article  Google Scholar 

Gulla C, Flo E, Kjome RL, Husebo BS. Deprescribing antihypertensive treatment in nursing home patients and the effect on blood pressure. J Geriatr Cardiol. 2018;15(4):275–83.

PubMed  PubMed Central